Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02IVU
|
||||
| Former ID |
DNC008859
|
||||
| Drug Name |
CACOSPONGIONOLIDE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534672] | ||
| Formula |
C25H36O4
|
||||
| Canonical SMILES |
CC1CCC23CC2(CCCC3C1(C)CCC4=CCC(OC4)C5=CC(=O)OC5O)C
|
||||
| InChI |
1S/C25H36O4/c1-16-8-12-25-15-23(25,2)10-4-5-20(25)24(16,3)11-9-17-6-7-19(28-14-17)18-13-21(26)29-22(18)27/h6,13,16,19-20,22,27H,4-5,7-12,14-15H2,1-3H3/t16-,19+,20+,22+,23-,24-,25-/m0/s1
|
||||
| InChIKey |
FPUWYDSKOKLTDH-FRMRWZTPSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Phospholipase A2, membrane associated | Target Info | Inhibitor | [534672] | |
| Phospholipase A2 | Target Info | Inhibitor | [534672] | ||
| BioCyc Pathway | PhospholipasesLIPASYN-PWY:Phospholipases | ||||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Ether lipid metabolism | |||||
| Arachidonic acid metabolism | |||||
| Linoleic acid metabolism | |||||
| alpha-Linolenic acid metabolism | |||||
| Metabolic pathways | |||||
| Ras signaling pathway | |||||
| Vascular smooth muscle contraction | |||||
| Pancreatic secretion | |||||
| Fat digestion and absorptionhsa00564:Glycerophospholipid metabolism | |||||
| Fat digestion and absorption | |||||
| Pathway Interaction Database | Glypican 1 networkfcer1pathway:Fc-epsilon receptor I signaling in mast cells | ||||
| References | |||||